Biogen Value-Based Contract Links Patient-Reported Outcomes To MS Drug Reimbursement

 
• By Cathy Kelly

Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.

woman using a wheelchair in a park - Image
Biogen Contract With UPMC Will Focus On Worsening Physical DIsability

More from Pricing Debate

More from Market Access